Using an intelligent traffic light system, Biotronik Home Monitoring quickly and easily identifies patients with the most clinically relevant events to streamline clinic workflow and improve patient care, the company said.
Biotronik has also established a large, multinational clinical trial program to provide even more evidence that Home Monitoring can improve patient care and at the same time, optimize clinic resources.
According to the company, Biotronik Home Monitoring is the only system available on the market that enables remote device follow up at any time.
Marlou Janssen, vice president of global marketing and sales for cardiac rhythm management at Biotronik, said: “With this important European approval of our new Biotronik Home Monitoring system, our leadership in telecardiology for patient with cardiac devices has been reconfirmed. We will launch the new Biotronik Home Monitoring platform at the beginning of October with limited availability to selected clinics throughout the world and complete the launch process in early 2009.”